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Summary  
 
The mechanisms by which cells compensate for 
volume fluctuations are not clearly understood and 
vary among species.  Research efforts in our lab 
have focused on elucidating the pathways involved 
in regulatory volume decrease (RVD), the process 
activated in response to cell swelling that allows for 
volume recovery.  Previously, fluorescence 
microscopy studies performed by Light et al. (2005) 
revealed that in salmon red blood cells, cell 
swelling elicits a rise in intracellular Ca2+ 
concentration (visualized using fluorescence 
microscopy and the Ca2+ indicator fluo-4-AM).  This 
was most likely due Ca2+ influx from the 
extracellular environment, because it was not 
observed in cells bathed in a hypotonic, low Ca2+ 
medium.  The goal of this study, therefore, was to 
confirm a role for extracellular Ca2+ in the RVD 
response, using both Salmo salar (Atlantic salmon) 
and Alligator mississippiensis (American alligator) 
red blood cells.  This was done by exposing cells to 
different extracellular environments and 
pharmacological agents that block Ca2+ influx 
pathways or Ca2+-mediated intracellular signaling 
cascades.  To asses the effects of these 
manipulations on RVD, median cell volume 
changes over a 90 minute time course were 
determined by electronic sizing using a Coulter 
counter.  Salmon cells exposed to a low Ca2+ 
environment failed to recover from cell swelling, 
indicating that extracellular Ca2+ was needed for a 
successful RVD response.  Similarly, volume 
regulation of alligator red blood cells occurred by a 
Ca2+-dependent mechanism.  Additionally, RVD in 
alligator cells appeared to occur through an 
intracellular signaling cascade involving Ca2+ 
activation of phospholipase A2 and the subsequent 
formation of arachidonic acid.  Arachidonic acid 
itself, as opposed to one of its potential breakdown 
products, aided in volume recovery by stimulating 
K+ efflux. In conclusion, the results from this study 
indicate that Ca2+ plays a pivotal role in the RVD 
response of both salmon and alligator red blood 
cells.  
 
Introduction 
 
Cells are the basic building blocks of all life forms, no 
matter how simple or complex.  In fact, despite the 
enormous diversity that exists among organisms, all 
have the same basic level of organization in that they 
are composed of one or more cells.  Although cell 
morphology and physiology may vary, both within an 
organism and among species, all cells conform to a  
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common function: maintaining a homeostatic balance, 
both within the intracellular environment and between 
the intracellular and extracellular environments (Lang & 
Waldegger 1997).  Securing this steady-state 
equilibrium is not an easy task, as there are 
unavoidable instances over the course of a cell’s life in 
which homeostasis may be challenged (O’Neill 1999).  
Fortunately, cells have acquired distinctive features that 
aid in preventing cellular imbalance and recovering 
from inevitable challenges. 
 One such feature is the plasma membrane, 
which is responsible for compartmentalizing the cell and 
allowing metabolic processes crucial for cell survival to 
take place in isolation from the external environment 
(Schultz 1989).  The basic structure of the plasma 
membrane is a phospholipid bilayer embedded with 
proteins (Goodman 2002).  The phospholipids that 
compose the membrane form a stable bilayer as a 
result of their amphipathic nature; they possess both 
hydrophobic phosphate moieties and hydrophilic 
hydrocarbon tails.  As a result of this composition, the 
plasma membrane permits the selective movement of 
fat-soluble solutes, both in and out of the cell, in 
accordance with the concentration gradient established 
between the extracellular and intracellular environments 
(Goodman 2002).  For ions or molecules that cannot 
readily traverse the membrane, either due to their size 
or charge, carriers and channels allow for their 
transport (Goodman 2002).  This transport may be 
active, if the molecule or ion is moving against its 
concentration gradient, or passive, if the molecule or 
ion is moving with its concentration gradient (McCarty & 
O’Neil 1992).  Both types of transport, active and 
passive, play a role in daily cellular function and are 
necessary for proper communication between the cell 
and its surroundings. 
Active transport of molecules across the 
plasma membrane requires both energy and the 
assistance of a pump (O’Neill 1999).  Protein pumps 
function to recognize and bind a specific substrate 
molecule and transfer that molecule across the 
membrane in the direction that opposes its 
concentration gradient (Singer & Nicolson 1972).  This 
process requires energy input, often in the form of ATP 
(Singer & Nicolson 1972).  In contrast, other carriers 
transport molecules with their concentration gradient; 
this passive process is known as “facilitated diffusion” 
(Singer & Nicolson 1972).   
Protein channels function as pores that shield 
water-soluble ions from direct contact with the lipid 
bilayer, thus allowing the ions to travel passively into or 
out of the cell (Lewis & Donaldson 1990).  These 
channels are often highly regulated, with this regulation 
being dependent on both the type of channel and the 
specific membrane in which the channel is embedded.  
For example, some channels are ligand gated, in which 
the binding of a signal molecule to the channel leads to 
its opening or closing (Singer & Nicolson 1972).  In 
contrast, other channels are voltage gated, where a 
change in membrane potential either activates or 
deactivates the channel (Lewis & Donaldson 1990).  Ion 
channels may also be mechanically gated such that 
mechanical stress or distortion to the plasma 
membrane controls the channel’s activity (O’Neill 1999).  
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Having numerous membrane channels and multiple 
gating mechanisms at their disposal allow cells to 
detect different types of perturbations and respond 
accordingly. 
Carriers, pumps, and ion channels are 
distinct from one another in their affinity and specificity 
for a given solute.  Despite these differences, they all 
function similarly to assist the cell in responding to 
physiological conditions by altering plasma membrane 
permeability to certain molecules and ions (O’Neill 
1999).  This change in permeability, in turn, adjusts 
intracellular solute concentration and affects the 
osmotic gradient between a cell and its surrounding 
medium (O’Neill 1999).  As a result, the movement of 
osmotically obligated water occurs in coordination with 
solute transport (Lang & Waldegger 1997).  This water 
and solute flux across the plasma membrane is linked 
to a major cellular threat: a change in cell volume 
(McCarty & O’Neil 1992). 
The difference in osmolality (i.e., the number 
of dissolved particles per kg H2O) existing between two 
media separated by a semi-permeable membrane 
determines the direction of water flow between them.  
Specifically, water will travel passively across the 
membrane from a medium of lower osmolality (more 
dilute) to higher osmolality (more concentrated); this 
process is termed osmosis (Lang & Waldegger 1997).  
Because cells are bathed in an extracellular medium, 
an osmotic gradient might exist between the 
intracellular and extracellular environments.  
Consequently, if the osmolality inside the cell is greater 
than the osmolality outside the cell, water will travel 
passively into the cell, resulting in cell swelling.  In 
contrast, if the solute concentration within the cell is 
lower than the solute concentration of the extracellular 
environment, water will diffuse out of the cell, and the 
cell will shrink.  Such cell volume changes are 
characteristic of organisms composed of cells that are 
faced with variable extracellular solute concentrations 
(O’Neill 1999).  For example, many intertidal animals 
are exposed to an external medium that dramatically 
and continually changes salinity due to environmental 
factors, such as evaporation, rainfall, and tidal 
movements of water (Vidolin et al. 2002).  Similarly, the 
gill epithelia of many teleosts, particularly euryhaline 
species, are bathed in external environments of 
fluctuating salinity (Kultz 2002).  Such fluctuations may 
lead to volume changes at the cellular level. 
Even cells bathed in a fairly invariable 
extracellular medium experience shifts in cell volume as 
a result of changes in intracellular osmolality, which can 
occur from a variety of cellular processes (O’Neill 
1999).  For example, the cortical proximal tubule cells 
of the kidney are challenged with significant fluctuations 
in intracellular osmolality as a consequence of their role 
in water and nutrient resorption (Linshaw 1991).  
Similarly, the crucial role that intestinal cells play in 
solute absorption leads to changes in the number of 
osmotically active particles within them and, in turn, 
changes in their volume (O’Neill 1999).  Further, the 
protein synthesis and degradation that occur in 
nucleated cells lead to osmotic perturbations, as the 
synthesis of proteins from amino acids reduces 
intracellular osmolality, whereas the degradation of 
proteins into amino acid monomers increases 
intracellular osmolality (Lang & Waldegger 1997).  
Clearly, some cell volume fluctuations are unavoidable 
events that occur as a result of common cellular 
activities and metabolic functions.   
Extreme volume changes, changes that a cell 
would not typically face under normal physiological 
conditions, can be induced in vitro.  The direct effects of 
such perturbations on cell homeostasis have been 
determined experimentally by placing cells in either 
dilute or concentrated extracellular media.  These 
experiments have shown that drastic shifts in 
extracellular osmolality result in rapid cell swelling or 
shrinking and are accompanied by altered cellular 
functioning (Schultz 1989).  For example, the 
expression of certain genes is osmosensitive, and the 
activating or deactivating effects that changes in cell 
volume have on these genes alter the expression of the 
proteins for which they encode (Lang & Waldegger 
1997).  Additionally, some genes cannot tolerate abrupt 
changes in cell volume, so such perturbations result in 
deleterious effects on the metabolic and enzymatic 
activities they control (Kultz 2002).  In the most basic 
sense, the mechanical strain imposed on a cell from 
volume fluctuations affects cell morphology and may 
even threaten cellular existence altogether; a cell can 
only expand to a given point before bursting or shrink to 
a given point before shriveling up in atrophy (McCarty & 
O’Neil 1992).  Thus, to prevent the potential loss of cell 
integrity resulting from cell swelling or shrinkage, it is 
crucial that a cell be able to employ specific recovery 
mechanisms.   
These mechanisms do exist in a wide 
number of cell types.  Specifically, certain cells are able 
to respond to and recover from hypotonic or hypertonic 
shock by activating the compensatory processes known 
as regulatory volume decrease (RVD) or regulatory 
volume increase (RVI) (Chamberlin & Strange 1989).  
Regulatory volume increase is the process by which a 
cell counteracts cell shrinkage by activating intracellular 
processes that increase cell volume through solute and 
water uptake.  In contrast, RVD is the compensatory 
response by which cells decrease their volume through 
the loss of solutes and water to recover from exposure 
to a dilute extracellular medium and subsequent 
swelling (McCarty & O’Neil 1992).  The fact that RVI 
and RVD allow for cell volume restoration following 
instances of severe anisosmotic stress make them 
critical parts of the cellular machinery.  This explains 
why they are such highly conserved mechanisms; 
indeed, rudimentary cell volume regulatory processes 
occur in most prokaryotic cells (Schultz 1989).  
The processes involved in RVD have been 
studied extensively in many cell types.  In those studied 
to date, such as human ciliary epithelial cells (Adorante 
& Cala 1995), Necturus red blood cells (Bergeron et al. 
1996), Erlich ascites tumor cells (Hoffman et al. 1986), 
and Madin-Darby canine kidney cells (Rothstein & 
Mack 1992), the RVD mechanism activated by cell 
swelling ultimately leads to net K+ and Cl- efflux.  This 
efflux is essential for volume recovery, as it reverses 
the driving force for water flux across the membrane.  
The intracellular signaling cascades that result in K+ 
efflux have also been examined, and some of these 
cascades involve protein kinase C (PKC) (McCarty & 
O’Neil 1992).   For instance, in Necturus red blood 
cells, RVD occurs through a PKC-dependent cascade 
that eventually results in the loss of K+ and Cl- from 
cells (Light et al. 1998).  Similarly, changes in cell 
volume and cell volume recovery mechanisms in 
astrocytes are PKC-sensitive (Bender et al. 1992). 
Additional intracellular messengers have 
been shown to play a role in activation of K+-Cl- loss, 
such as calmodulin and arachidonic acid.  Calmodulin 
is a Ca2+ binding protein involved in many biological 
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pathways, including cell volume regulation in certain 
cell types (Huang et al. 2001).  Specifically, activation of 
this cellular messenger is crucial for RVD in astrocytes 
(Quesada et al. 1999, Bender et al., 1992), and 
Necturus red blood cells depend on calmodulin for a 
successful RVD response (Bergeron et al. 1996).  
Arachidonic acid metabolites, called eicosanoids, are 
also involved in volume recovery mechanisms.  For 
example, eicosanoids mediate RVD in trout proximal 
renal tubules (Kanli & Norderhus 1998).  Similarly, a 5-
lipoxygenase metabolite of arachidonic acid is involved 
in regulation of Necturus cell volume (Light et al. 1997).  
Clearly, the intracellular processes involved in volume 
decrease are often rather complex, with numerous cell 
signaling agents working in coordination to activate and 
carry out the RVD response. 
Despite the necessity of K+-Cl- efflux for cell 
volume recovery, large shifts in the intracellular 
concentrations of such ions can have destabilizing 
effects on cells (Lang & Waldegger 1997).  Therefore, 
the loss of organic solutes, such as sugars and amino 
acids, is also commonly involved in cell volume 
regulation (Chamberlin & Strange 1989).  For example, 
loss of the amino acid taurine has been implicated in 
the RVD processes that take place in trout erythrocytes 
(Garcia-Romeu et al. 1991, Huang et al. 2001), and in 
Ehrlich ascites tumor cells, both taurine and glycine 
efflux occur following cell swelling (Hoffman & Lambert 
1983).  A cell’s ability to use organic osmolytes to 
adjust intracellular solute concentration is 
advantageous, as the loss of many of these molecules 
does not cause deleterious effects on cell functioning 
(Chamberlin & Strange 1989).  This is of key 
importance because preventing cell damage from 
volume fluctuations must not occur at the cost of ionic 
imbalance, as this could also be detrimental to cell 
integrity. 
Despite what has been learned regarding cell 
volume regulatory mechanisms, much is still unknown 
concerning the initial steps that lead to activation of 
RVD.  In particular, the role that Ca2+ plays in RVD 
initiation and signal transduction is widely debated.  
Calcium is known for the essential role it plays in many 
cellular processes, such as muscle contraction 
(Martonosi 2000) and neurotransmission (DeLorenzo 
1981), but its utility extends much further.  For example, 
Ca2+ is involved in activities that range from inducing 
apoptosis (programmed cell death) (Orrenius et al. 
2003) to stimulating sperm motility in carp (Krasznai et 
al. 2000).   
A role for this signal molecule has also been 
identified in the volume regulatory processes of 
numerous cell types, including human ciliary epithelial 
cells (Adorante & Cala 1995), choroids plexus epithelial 
cells (Christensen 1987), Necturus red cells (Light et al. 
1999), Madin-Darby canine kidney cells (Rothstein & 
Mack 1992), proximal tubules (McCarty & O’Neil 1990), 
and rat lacrimal acinar cells (Speake et al. 1998).  In 
these cell types, Ca2+ plays an important role in 
activating intracellular events that culminate in solute 
efflux.  However, in other biological systems, Ca2+ is not 
essential for volume recovery, although it does assist in 
achieving an optimal RVD response.  This is the case 
for rat liver cells (Bear 1990) and cultured astrocytes 
(Quesada et al. 1999).  In contrast, findings from other 
research indicate either an RVD scheme completely 
independent of Ca2+ or a mechanism by which a rise in 
Ca2+ during cell swelling is a non-crucial 
epiphenomenon.  For example, rat cerebellar 
astrocytes employ a volume recovery response that  
 
Figure 1. A rise in intracellular Ca2+ accompanies hypotonic 
shock in salmon red blood cells.  
  
The amount of fluorescence visible in red blood cells loaded 
with fluorescent dye (fluo-4, 10 µ M) and exposed to UV light 
was dependent on the extracellular medium the cells were 
bathed in.  (A) Cells bathed in isosmotic solution failed to 
fluoresce. (B) Cells treated with the Ca2+ ionophore A23187 
(positive control) in an isosmotic solution displayed 
fluorescence.  (C)  Exposure to hypotonic shock increased the 
degree of fluorescence in the red blood cells.  (D)  When Ca2+ 
was buffered to 10 nM with EGTA in a hypotonic medium, no 
fluorescence was observed.  The above fluorescent microscopy 
studies were conducted by Light et al. (2005). 
 
lacks Ca2+ involvement (Morales-Mulia et al. 1998), as 
do trout proximal renal tubules (Kanli & Norderhus 
1998) and trout erythrocytes (Garcia-Romeu et al. 
1991).  Clearly, whether a dependency on Ca2+ for RVD 
exists is controversial and appears to vary among cell 
types.  Furthermore, for those cell types in which Ca2+ 
does appear to play a role in volume restoration, the 
exact pathway by which it operates has yet to be 
determined. 
The goal of my research was to help clarify 
the inconclusive relationship between Ca2+ and 
regulatory volume decrease.  To do so, I studied the 
effects of Ca2+ manipulation on RVD in both Atlantic 
salmon (Salmo salar) and American alligator (Alligator 
mississippiensis) erythrocytes, in an effort to determine 
whether the signal transduction pathways stimulated by 
cell swelling are Ca2+-dependent or Ca2+-independent.  
Previous research in our laboratory provides evidence 
for potential involvement of Ca2+ in the RVD response 
of salmon red blood cells (Light et al. 2005).  Using 
fluorescent microscopy, Light et al. (2005) tracked 
changes in the intracellular Ca2+ of the cells (Figure 1).  
They observed that cells bathed in an isosmotic 
medium displayed virtually no fluorescence, which was 
indicative of low Ca2+ levels under basal conditions.  
However, exposure to a dilute extracellular environment 
elicited a dramatic increase in fluorescence, which 
suggests that salmon cells experience a rise in 
intracellular Ca2+ in response to hypotonic shock.   
Based on the findings of Light et al. (2005), 
my aim was to characterize the role of Ca2+ in RVD 
further.  Specifically, my study rested on the following 
three hypotheses: 1) Cell swelling is accompanied by a 
rise in intracellular Ca2+ necessary to stimulate RVD, 2) 
the source of this Ca2+ is extracellular, and 3) Ca2+ 
activates an intracellular event essential for volume 
recovery.  If RVD does indeed depend on extracellular 
Ca2+, then I expected removing this Ca2+ source would 
inhibit the volume recovery response.  In contrast, if 
RVD is Ca2+-independent, then Ca2+ removal should 
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have no effect on the ability of cells to regulate their 
volume following hypotonic challenge.  Additionally, 
blocking Ca2+ entry into cells using Ca2+ transport 
antagonists should inhibit RVD if Ca2+ influx is required 
to facilitate the volume recovery process. However, if 
Ca2+ influx is not an essential step, then no effect 
should be observed following inhibition of Ca2+ 
permeability pathways.  Lastly, if the role of Ca2+ is to 
stimulate an intracellular signaling cascade crucial for 
volume recovery, then blocking the signaling events 
occurring downstream of Ca2+ activation should also 
result in the failure of cells to respond appropriately to 
anisosmotic challenges.  But if these Ca2+-activated 
signaling events are not involved in RVD, antagonizing 
them should not inhibit volume regulation. 
I chose to focus on salmon and alligator cells 
because the lifestyles of these organisms suggest that 
they would be good models for studies on cell volume 
recovery.  In particular, salmon are euryhaline marine 
teleosts, meaning they can tolerate both freshwater and 
saltwater environments (Handeland et al. 1996).  They 
are also anadromous, making multiple migratory trips 
between freshwater and saltwater throughout the 
course of their lives (Handeland et al. 1996).  The fact 
that they are able to adapt to such varying degrees of 
salinity suggests that their cells, which may come in 
contact with the extracellular environment during 
transport through the gills, have a finely-tuned 
mechanism for coping with cell volume deviations.   
Likewise, although alligators are primarily 
found in freshwater, they can tolerate abbreviated 
episodes in brackish environments (Richards et al. 
2004).  Additionally, they hibernate during the winter 
and can also endure freezing conditions for short 
periods of time (Lance & Elsey 1999).  Hibernation 
results in reduced blood flow to the kidneys and 
consequent reduced renal activity (Zancanaro et al. 
1999).  Kidney cells play a crucial role in adjusting 
extracellular fluid osmolarity.  Therefore, abrupt 
changes in kidney cell activity as a result of hibernation 
could result in cell volume changes.  In addition, 
exposure of alligators to freezing conditions has a fairly 
rapid stimulatory effect on stress hormone production, 
which initiates a change in plasma ion concentration 
(Lance & Elsey 1999).  A more long-term effect of such 
exposure includes retardation of protein synthesis 
(Lance & Elsey 1999).  As stated earlier, such changes 
in osmolyte concentrations correspond with a shift in 
the osmotic gradient between intracellular and 
extracellular environments and, consequently, lead to 
either cell swelling or shrinkage (McCarty & O’Neil 
1992).  Therefore, the ability of alligators to cope with 
such challenges is presumably allowed for, at least in 
part, by a well-developed cell volume regulatory 
mechanism. 
In addition, unlike mammalian erythrocytes, 
red blood cells from salmon and alligators are 
nucleated.  This allows for protein synthesis and 
degradation to take place within them (Lang & 
Waldegger 1997), activities that alter intracellular 
osmolality.  This suggests that the red blood cells of 
both species may be adapted to deal with shifts in 
solute concentration (Lang & Waldegger 1997).  
Furthermore, these cells are free floating, so they do 
not require a substrate on which to grow.  Additionally, 
the characteristic pigmentation of these cells makes 
osmotic fragility studies possible. 
The continuation of research in this field 
promotes a better understanding of cell physiology, and 
uncovering the underlying processes involved in RVD 
has practical applications, as well, including the study of 
certain pathophysiological conditions.  For example, 
apoptosis is the process by which cells marked for 
destruction lose water and solutes in a feed-forward 
mechanism until they are reduced to a size that can be 
easily engulfed by phagocytic cells (Okada & Maeno 
2001).  Overactive or dysfunctional apoptosis are 
characteristic of diseases including neurodegeneration 
and cancer (Okada & Maeno 2001).  The obvious 
parallels between apoptosis and RVD, mainly that both 
proceed in a controlled manner that allows for volume 
reduction (Okada & Maeno 2001), suggest that 
clarification of the RVD pathway may be useful when 
developing methods for either inducing apoptosis in 
apoptotically deficient cells or inhibiting it in cells 
displaying overactive apoptosis.   
Another disease state related to RVD in its 
mechanics is ischemia, which is characterized by a lack 
of oxygenated blood flow to cells and often 
accompanies a blood clot or stroke (Pasantes-Morales 
et al. 2000).  One of the hallmark events that occurs 
during ischemia is significant cell swelling. 
Subsequently, ischemic cells are able to recover from 
this swelling by the loss of K+ and organic osmolytes 
(Pasantes-Morales et al. 2000).  However, the recovery 
rarely occurs quickly enough to prevent some amount 
of cell damage (Diaz et al. 2003).  It has been proposed 
that enhancing the rate of cell volume recovery may be 
the key to preventing irreversible damage to these cells 
(Diaz et al. 2003).  To develop a method for quickening 
this rate, further research on cell volume recovery 
processes is needed. 
Finally, while similarities can be recognized 
between RVD, apoptosis, and ischemia, other disorders 
are largely the direct consequence of insufficient or 
faulty cell volume regulation.  These include renal 
disease, diabetes mellitus, dehydration, and cerebral 
edema (McManus et al. 1995).  The potential for 
developing better techniques for managing these 
disease states lies in the ability to elucidate the 
pathways involved in the underlying cell volume 
regulatory mechanisms. 
 
Materials and Methods 
Experimental Design 
 
The first hypothesis I set out to test was whether 
extracellular Ca2+ is necessary for RVD.  Presumably, if 
extracellular Ca2+ is required for a successful RVD 
response, then in its absence cells should fail to 
regulate their volume effectively.  However, this 
manipulation should have no effect if RVD is Ca2+-
independent.  To distinguish between these two 
possibilities, I carried out calcium influx studies in which 
Ca2+ was removed from the extracellular environment 
using the extracellular Ca2+ chelator ethylene glycol-
bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid 
(EGTA).  Additionally, I performed experiments where 
plasma membrane permeability to Ca2+ was increased 
using A23198, an ionophore that facilitates Ca2+ entry 
into cells (Light et al. 2003).  I expected this to have the 
opposite effect of removing Ca2+.  That is, increasing 
Ca2+ influx should enhance RVD if Ca2+ plays a role in 
stimulating the volume regulatory response.   
If the results of the above studies supported 
my first hypothesis (i.e., Ca2+ is necessary for RVD and 
is extracellular in origin), I next wanted to characterize 
the Ca2+ influx pathways activated subsequent to cell 
swelling to identify how Ca2+ was entering cells.  There 
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are three main entry sites that could facilitate Ca2+ 
influx: stretch-activated channels, ligand-gated 
channels, and voltage-sensitive channels (McCarty & 
O’Neil 1992).  Stretch-activated channels have been 
shown to be a major site for Ca2+ entry in numerous cell 
types (McCarty & O’Neil 1992).  For example, 
Christensen (1987) concluded that hypotonic shock 
stimulates the opening of stretch-activated channels 
that are permeable to Ca2+ in the plasma membrane of 
choroids plexus epithelia.  Also, Hoyer et al. (1994) 
named stretch-activated ion channels as the site of 
Ca2+ entry following hypotonic exposure of porcine 
endocardial endothelia.  Ligand-gated cation channels, 
such as P2 receptors, also allow significant amounts of 
Ca2+ to cross the plasma membrane of many cells, 
including red blood cells (Ralevic & Burnstock 1998).  
Light et al. (2003), for example, showed P2 receptors as 
a likely site for Ca2+ entry into Necturus red blood cells 
following hypotonic shock.  In contrast to stretch-
activated and ligand-gated channels, voltage-sensitive 
channels are typically restricted to neurons and muscle 
cells (Jones 1998).  Accordingly, I decided to first 
examine those entry pathways that have been strongly 
implicated in solute influx during RVD. 
To address the role of stretch-activated 
channels in RVD, I used the pharmacological agents 
lanthanum and gadolinium.  Lanthanum is a broad-
spectrum Ca2+ channel inhibitor, but it shows some 
selectivity toward stretch-activated channels, which 
tend to be permeable to Ca2+ (Yang & Sachs 1989).  
Gadolinium primarily blocks stretch-activated channels, 
but there is some evidence suggesting that this agent 
also antagonizes P2 receptors (Nakazawa et al. 1997).  
These agents have proven to be potent inhibitors in 
many cell volume studies.  For example, Adorante & 
Cala (1995) and Rothstein & Mack (1992) found that 
treating cells with lanthanum has an inhibitory effect on 
cell volume recovery following hypotonic shock of 
nonpigmented human ciliary epithelial cells and Madin-
Darby canine kidney cells, respectively.  Light et al. 
(2003) discovered that Ca2+ entry into Necturus red 
blood cells after hypotonic shock occurs through a 
gadolinium-sensitive channel, as use of this agent 
inhibits volume recovery.  Similar RVD inhibition in 
response to gadolinium treatment was observed in rat 
lacrimal acinar cells by Speake et al. (1998).  
Accordingly, I expected volume recovery to be 
weakened in the presence of these Ca2+ transport 
antagonists if their sites of action correlate with the 
calcium entry pathways active during RVD of salmon 
and alligator cells, whereas they should have no effect 
on volume recovery if they act on influx pathways not 
involved in the volume regulatory responses of these 
cell types.   
To further determine the entry site for Ca2+, I 
examined the effects of targeting P2 receptors, 
specifically the P2X class, which .are ATP-gated, Ca2+ 
permeable channels (Nakazawa et al. 1997).  To 
address whether they are involved in the RVD process, 
I utilized the ATP scavenger hexokinase, as 
extracellular ATP has been shown to stimulate RVD in 
several cell types by activating P2 receptors (Dezaki et 
al. 2000, Light et al. 2001, Schwiebert et al. 1995).  
Hexokinase can be used to remove this ATP source in 
the presence of glucose, thus preventing P2 receptor 
activation (Schwiebert et al. 1995).  In addition, I 
directly inhibited P2 receptors using suramin, an agent 
that binds to and inactivates this receptor type (Dezaki 
et al. 2000).  If P2 receptors play a role in Ca2+ entry 
following hypotonic shock, then these agents should 
have an attenuating effect on RVD.  I also attempted to 
potentiate volume recovery by adding ATP to the 
extracellular medium.  I predicted that if P2 receptors 
are indeed involved in volume regulation, then this 
addition should have the opposite effect of hexokinase 
and suramin, and thus stimulate a decrease in cell 
volume.  
After studying the processes by which Ca2+ 
entered cells, I wanted to address my hypothesis that 
Ca2+ functions as an intracellular messenger to activate 
an event necessary for volume recovery.  I 
accomplished this by first determining whether K+ efflux 
is required for a decrease in cell volume, and whether 
this efflux is Ca2+-dependent, as K+ loss from swollen 
cells is a necessary step in RVD of virtually all cell 
types that have been studied (Adorante & Cala 1995, 
Bergeron et al. 1996, Hoffman et al. 1986, Rothstein & 
Mack 1992).  To do so, I observed the effects of 
enhancing K+ efflux with gramicidin.  This agent 
increases plasma membrane permeability to K+ by 
forming pores in the cell membrane specific for 
monovalent cations, thereby allowing for the movement 
of cations either in or out of the cell as dictated by their 
electrochemical gradients (Light et al. 1998).  In my 
studies, I was able to make these pores essentially K+ 
specific by removing Na+ from the extracellular 
environment and replacing it with choline (a large, 
impermeant cation that does not readily traverse the 
plasma membrane, nor alter RVD).  In doing so, I could 
assess whether RVD is dependent on K+ efflux, and 
whether K+ efflux, in turn, is dependent on Ca2+.  If this 
is indeed the case, then bypassing the Ca2+-dependent 
step (with gramicidin) should reverse the inhibitory 
effects of placing cells in a hypotonic, Ca2+-free 
solution. 
Then, I sought to establish whether Ca2+ acts 
as a direct modulator of K+ efflux or, alternatively, if it 
plays an indirect role by acting as a second messenger.  
To this end, I inhibited Ca2+-activated K+ channels using 
quinine, a selective blocker of this channel type 
(Hoffman et al. 1986), expecting to observe a reduction 
in RVD upon doing so if K+ loss from cells occurred by 
this route.  I also examined the potential role Ca2+ might 
play as an intracellular messenger by targeting different 
Ca2+-activated signal transduction pathways that could 
ultimately lead to K+ efflux.  One pathway I thought 
could be involved was calmodulin, which plays a role in 
the RVD signaling cascade of the astrocytes studied by 
both Quesada et al. (1999) and Bender et al. (1992), 
Necturus erythrocytes studied by Bergeron et al. 
(1996), and the human erythroleukemia cells studied by 
Huang et al. (2001).  In these cells, inhibition of 
calmodulin resulted in a reduced ability of cells to 
regulate their volume while under hypotonic challenge.  
I assessed a potential role for calmodulin in volume 
recovery using pimozide, an antagonist of calmodulin 
activity (Bergeron et al. 1996, Hoffman et al. 1986, 
Huang et al. 2001).  Hypothetically, if calmodulin-
dependent signaling occurs downstream of Ca2+ and is 
required to stimulate volume decrease, then inhibiting 
calmodulin should correlate with a reduced RVD 
response. 
In addition, I targeted the enzyme 
phospholipase A2, whose activation results in the 
formation of arachidonic acid.   Metabolites of 
arachidonic acid, in particular, leukotrienes, have been 
implicated in the RVD response in a diverse number of 
cell types (Kanli & Norderhus 1998, Light et al. 1998, 
Pasantes-Morales et al. 2000).  The first step in 
determining whether arachidonic acid or its metabolites 
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Agent Function Predicted Effect on RVD 
 
EGTA 
 
Extracellular calcium chelator 
 
Inhibition if Ca2+ is necessary for volume recovery 
 
A23187 
 
Calcium ionophore 
 
Enhancement if Ca2+ influx stimulates RVD 
 
Gadolinium 
 
Stretch-activated channel blocker 
 
Inhibition if Ca2+ influx occurs through a SA channel 
 
Lanthanum 
 
Stretch-activated channel blocker 
 
Inhibition if Ca2+ entry occurs through a SA channel 
 
Hexokinase 
 
ATP scavenger 
 
Inhibition if Ca2+ entry occurs through a P2 receptor 
 
Suramin 
 
P2 receptor antagonist 
 
Inhibition if Ca2+ entry occurs through a P2 receptor 
 
ATP 
 
Natural ligand for P2 receptors 
 
Enhancement if P2 receptor activity facilitates RVD 
 
Gramicidin 
 
Ionophore for monovalent cations 
 
Enhancement of K+ efflux is required for volume recovery 
 
Quinine 
 
Ca2+-activated K+ channel blocker 
 
Inhibition if K+ efflux occurs via a Ca2+-activated K+ channel 
 
Pimozide 
 
Calmodulin antagonist 
 
Inhibition if RVD requires calmodulin activation 
 
ONO-RS-082 
 
Phospholipase A2 inhibitor 
 
Inhibition if volume recovery is PLA2-dependent 
 
2,3 DBAP 
 
Phospholipase A2 inhibitor 
 
Inhibition if volume recovery is PLA2-dependent 
 
ETYA 
 
Antagonist of eicosanoid synthesis 
 
Inhibition if an eicosanoid stimulates RVD 
 
NDGA 
 
Antagonist of leukotriene production 
 
Inhibition if a leukotriene is needed for volume decrease 
 
Table 1.  Pharmacological agents used in cell volume studies, their functions, and my predictions as to their effects on regulatory 
volume decrease. 
 
are involved in RVD of the cells I studied was to identify 
whether RVD is PLA2 dependent, because PLA2 (a 
Ca2+ activated enzyme) is responsible for arachidonic 
acid formation (Pasantes-Morales et al. 2000).  I used 
the PLA2 antagonists ONO-RS-082 and 2,4-
dibromoacetophenone to do this, as these agents have 
been shown to be useful PLA2 inhibitors in other RVD 
studies (Balsinde et al. 1999, Nakashima et al. 1989).  
If arachidonic acid or its metabolites are essential for 
volume recovery following hypotonic shock, then I 
expected to observe an inhibited volume recovery in 
response to preventing arachidonic acid formation.   
If my PLA2 inhibition studies implicated 
arachidonic acid formation as a necessary event in the 
RVD response, my next step would be to determine 
whether arachidonic acid itself modulates volume 
recovery, or, alternatively, if one of its metabolites 
(known as eicosanoids) does.  To distinguish between 
these two possibilities, I treated cells with the general 
eicosanoid antagonist 5,8,11,14-eicosatetraynoic acid 
(ETYA).  Additionally, I targeted the lipoxygenase 
pathway of arachidonic acid metabolism using 
nordihydroguaiaretic acid (NDGA), as this pathway has 
been shown to be activated during RVD of several cell 
types (Lambert et al. 1987, Light et al. 1997).  I 
predicted that if arachidonic acid, but not an eicosanoid, 
is required for RVD, then inhibiting eicosanoid formation 
should not affect the volume recovery response.  
However, if an eicosanoid is involved in volume 
regulation, then antagonizing the pathways responsible 
for forming the metabolite should inhibit the ability of 
cells to recover from cell swelling. 
Table 1 summarizes the experimental 
approach I used to test my hypotheses.  Listed are the 
various pharmacological agents I used and their modes 
 
 
of action.  Additionally, my predictions as to the effects 
of these agents are also given. 
 
Animals 
 
A common pool (3-4 fish) of salmon blood was 
purchased from Bioreclamation (Hicksville, NY).  
Alligator whole blood was purchased from Carolina 
Biological Supply (Burlington, NC). The blood was 
stored at 4oC for no longer than one month and was 
inverted daily. Visualization of salmon erythrocytes 
(Figure 2) was achieved using a Nikon phase contrast 
microscope (Fryer Co. Scientific Instruments, 
Carpentersville, IL) along with a mounted camera (Spot 
Insight Color and Spot software).  For visualizing 
alligator erythrocytes (Figure 2), a Nikon Eclipse 
TE2000-U DIC microscope (Fryer Co. Scientific 
Instruments, Carpentersville, IL) was used. 
 
Cell Volume 
 
A Z2™ COULTER COUNTER® with Channelyzer was 
used to electronically size and count red blood cells 
(Figure 3, Coulter Electronics, Fullerton, CA).  The 
aperture orifice was 100 µ m in diameter, and the 
metered volume was 0.5 ml.  The Coulter counter was 
calibrated using latex beads of known size.  Median cell 
volumes (fl) were obtained from distribution curves 
between 50 fl and 1200 fl.  The lower limit (50 fl) was 
chosen to prevent the counting of thrombocytes, which 
are smaller than red blood cells and comprise a 
significant portion of total blood volume (Histology of 
Blood, Creighton University Health Sciences 
Laboratory, www.hsl.creighton.edu).  Although white 
blood cells were counted, as they are approximately the  
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Figure 2. Salmon and alligator erythrocytes.  
(A) Salmon erythrocytes photographed at 400X.  The cells are 
approximately 15 µ m long and 11 µ m wide (Nash & 
Egginton 1993); as a comparison, this is about twice the size of 
human red blood cells.  They are oval in shape, free-floating, 
and, unlike mammalian red cells, they are nucleated.  (B)  
Alligator erythrocytes photographed at 1000X (taken by Spivak, 
Pore, & Silverman, Light Lab).  These oval-shaped cells 
measure approximately 21 µ m in length and 11 µ m in width 
(Hartman & Lessler 1964).  They are free-floating and 
nucleated. 
 
same size as red blood cells, the proportion of white 
cell to red cell is typically 1/1000 
(www.hsl.creighton.edu); therefore, their contribution 
was assumed to be insignificant.  Readings were taken 
from cell suspensions containing between 20,000-
40,000 cells over a time course of 90 min.  Specifically, 
median cell volumes were recorded at 30 sec intervals 
from 0 to 3 min, at 5 min, and at 10 min intervals from 
10 to 90 min.   
Using the volume measurements obtained 
from electronic sizing, two different assessments were 
made.  First, the final relative volume of experimental 
cells was compared to control cells, with relative 
volume being the absolute cell volume divided by the 
volume of untreated cells equilibrated in isosmotic 
solution.  This was done to determine differences in the 
overall degree by which cells reduced in size following 
hypotonic challenge.  Additionally, the rate of volume 
recovery was used to compare the RVD responses of 
experimental and control cells.  This was done by 
comparing the relative volume of experimental and 
control cells at both 40 and 90 min to the maximum 
relative volume of control cells.  To do so, the following 
formulas were used (Light et al. 1999):  percent volume 
recovery at time x is equal to [ (Vmax – Vx)/(Vmax – V0) ] x 
100%.  In this equation, Vmax represents maximum 
relative control cell volume, Vx represents the relative 
cell volume measured at time x, and V0 represents 
relative cell volume at time 0 min.  Overall percent 
volume decrease was determined as [ (percent 
recoveryexperimental)/percent recoverycontrol) ] x 100%. 
 
   
 
Figure 3.  Z2™ COULTER COUNTER® and aperture.  
The Coulter counter electronically sizes and counts cells based 
on a change in resistance that occurs as the cells pass through 
a narrow aperture opening.  Cell volume is proportional to this 
change in resistance (figure is courtesy of Beckman Coulter, 
Inc., www.beckmancoulter.com). 
 
Solutions and Reagents 
 
Isosmotic and hypotonic Ringer solutions were used to 
mimic blood plasma environments.  The compositions 
of the Ringers used in this study were based on those 
provided by the Marine Biology Laboratory in Woods 
Hole, MA (www.mbl.edu).  The osmolality and pH of all 
solutions were determined using a Vapor Pressure 
Osmometer (Wescor 5500) and an Accumet Basic 
AB15 pH meter (Fisher Scientific), respectively.   
For salmon, isosmotic high Na+ Ringer 
contained (in mM) 178 NaCl, 2.5 KCl, 2.0 CaCl2, 1.8 
MgCl2, 8.75 Hepes hemisodium salt, 1.25 Hepes, 5.5 
Glucose, and 1.0 NaHCO3.   Hypotonic high Na+ Ringer 
had the same composition, except the NaCl content 
was reduced to 67 mM.  Hypotonic low Ca2+ (10 nM 
free Ca2+) contained (in mM) 67 NaCl, 2.5 KCl, 0.5 
CaCl2, 4 EGTA, 1.5 MgCl2, 10 Hepes, 8 Trizma base, 
5.5 Glucose, and 1.0 NaHCO3.  The MAXC downloads 
website 
(http://www.stanford.edu/%7ECpatton/downloads.htm) 
was used to calculate the appropriate free Ca2+ 
concentration. 
For alligator, isosmotic high Na+ Ringer 
contained (in mM) 140 NaCl, 6 KCl, 6 CaCl2, 1.5 MgCl2, 
5.45 Hepes hemisodium salt, 4.55 Hepes, 5.5 Glucose, 
and 1.0 NaHCO3.   For the hypotonic high Na+ Ringer, 
NaCl content was reduced to 70 mM, and for the NaCl-
free hypotonic Ringer, NaCl was replaced with 70 mM 
choline chloride.  Hypotonic low Ca2+ (10 nM) Ringer 
contained (in mM) 62.5 NaCl, 6 KCl, 0.5 CaCl2, 1.5 
MgCl2, 3.8 EGTA, 5.45 Hepes hemisodium salt, 4.55 
Hepes, 9.16 Trizma base, 5.5 Glucose, and 1.0 
NaHCO3.   
All chemicals and pharmacological agents 
were acquired from Sigma Chemical Co. (St. Louis, 
MO), Axxora LLC (San Diego, CA), and ICN 
Biomedicals (Aurora, OH).  Aqueous stock solutions 
were made at 100X their final concentration and were 
then diluted 100X when used to achieve the final 
working concentration desired.  Nonaqueous stock 
solutions (using methanol, ethanol, or DMSO as 
vehicles) were made at 1000X their final concentration 
and diluted 1000X to their final working concentration 
(Light et al. 2001).  All experiments were carried out at 
room temperature (21-23oC). 
 
Statistics 
 
Cell volume changes were graphically represented 
using KaleidaGraph 4.0 (Synergy Software; Reading, 
 
 
A 
 
 
 
 
 
 
 
 
 
B 
120 
PA) and Microsoft Excel (Microsoft Corporation; 
Redmond, WA).  The statistical significance of the 
experimental results (i.e., differences in final cell 
volume and percent volume decrease of control cells 
compared to experimental cells) was assessed by 
performing either paired t-tests or analysis of variance 
(ANOVA) and multivariate analysis of variance 
(MANOVA).  Statistics were computed using Data Desk 
Software (Ithaca, NY). 
Each experiment was replicated at least five 
times.  Each maneuver was compared to its own 
control, allowing for paired comparisons.  A separate 
blood sample was used for each replicate experiment.  
All samples were taken from several common pools. 
 
Results 
 
Salmon 
 
Challenging salmon cells with a hypotonic (~0.5x) 
extracellular environment caused them to swell rapidly.  
Following this initial increase in volume, the cells 
gradually and spontaneously recovered toward their 
normal size over a 90 minute time course (Figure 4A).  I 
then bathed cells in a low Ca2+ medium to test whether 
RVD requires extracellular Ca2+.  There was a 
significant difference in final cell volume of cells bathed 
in the low Ca2+ hypotonic Ringer (buffered to 10 nM 
with EGTA) compared to that of control cells (Figure 
4A, n=5, P<0.001 at 90 min).  Additionally, in the low 
Ca2+ environment, percent volume recovery was 
inhibited both at 40 min and at 90 min (Figure 4B, n=5, 
P<0.001).  
The next series of experiments were 
designed to inhibit Ca2+ influx.  Surprisingly, cells 
treated with lanthanum (10 µ M, n=5), an inorganic 
inhibitor of Ca2+ channels (Rothstein & Mack 1992), 
displayed an enhanced volume recovery (Figure 5A, 
P<0.001 at 90 min compared to control).  The percent 
volume recovery was dramatically potentiated at both 
40 min and 90 min (Figure 5B, P<0.001 for both 40 and 
90 min), and the total percent volume decrease of 
lanthanum-treated cells compared to control cells was 
188%. 
 
Alligator 
 
Alligator erythrocytes swelled rapidly in response to 
hypotonic challenge (Figure 7A).  The initial swelling 
was followed by a subtle volume recovery.  However, in 
a hypotonic, low-Ca2+ extracellular medium, volume 
decrease was completely inhibited (Figure 7A, n=7, 
P<0.001 at 90 min compared to control cells).  
Specifically, in the absence of extracellular Ca2+, 
percent volume recovery was abolished (Figure 7B, 
n=7, P<0.01 at 40 and 90 min).  Upon examining 
whether the cationophore gramicidin would influence 
RVD by enhancing K+ efflux,  I found that addition of 
this agent (0.5 µ M added at peak cell volume, n=5) to 
a low Ca2+ choline Ringer reversed EGTA-mediated 
RVD inhibition.  In fact, despite the lack of an 
extracellular Ca2+ source, in the presence of gramicidin, 
final cell volume recovery exceeded that of control cells 
(Figure 7A, n=5, P<0.05 at 90 min), as did percent 
volume recovery at 90 min (Figure 7B, n=5, P<0.05). 
This I attempted to address my hypothesis that 
facilitating Ca2+ influx should potentiate volume  
recovery by increasing intracellular Ca2+ concentration 
using the Ca2+ ionophore A23187 (0.5 µ M, n=6).  
Unexpectedly, the ionophore had a pronounced 
inhibitory effect on the ability of alligator red blood cells 
to regulate their volume following hypotonic shock 
(Figure 8A, P<0.001 at 90 min compared to control 
cells).  Not only did A23187-treated cells fail to recover 
their volume, but they continued to swell throughout the 
90 min time course (Figure 8B, P<0.001 at 40 min and 
P<0.001 at 90 min). 
To examine the mechanism for Ca2+ influx 
into alligator cells, I used gadolinium (50 µ M, n=7).  
Unlike in salmon (Figure 6), this agent had a distinct 
inhibitory effect on cell volume recovery (Figure 9A, 
P<0.01 at 90 min compared to control cells).  That is, 
unlike control cells, percent volume recovery of 
gadolinium-treated cells was completely inhibited 
(Figure 9B, P<0.001 at 40 min and P<0.01 at 90 min). 
After observing an inhibitory effect following 
gadolinium treatment, I wanted to pinpoint the 
gadolinium-sensitive transport pathway involved in Ca2+ 
influx in response to cell swelling.  To this end, I 
examined whether P2X receptors were involved in the 
alligator RVD process.  To accomplish this, I utilized the 
ATP scavenger hexokinase (2.5 units/mL H2O, n=6), as 
extracellular ATP is known to enhance RVD by 
stimulating P2 receptors (Dezaki et al. 2000, Light et al. 
2001, Schwiebert et al. 1995).  Consistent with my 
prediction, this agent had a significant inhibitory effect 
on cell volume recovery, as hexokinase-treated cells 
were more swollen than control cells at 90 min (Figure 
10A, P<0.01).  Furthermore, upon hexokinase addition, 
percent volume recovery was reduced (Figure 10B, 
P<0.01 at 40 min and P<0.001 at 90 min). 
To further verify a role for P2 receptors, I 
treated cells with suramin (100 µ M, n=5), which 
directly inhibits this receptor type (Dezaki et al. 2000, 
Light et al. 2001).  Cells bathed in a hypotonic solution 
containing this agent showed a decreased ability to 
regulate their volume compared to control cells (Figure 
11A, p<0.05 at 90 min).  Furthermore, percent volume 
recovery of experimental cells was also limited in 
comparison to control cell percent volume recovery 
(Figure 11B, P<0.01 at both 40 and 90  min).   
After successfully inhibiting the RVD 
response of alligator cells using antagonists of P2 
receptor activation, I attempted to potentiate volume 
recovery using an agonist of this receptor type.  I 
provided cells with an exogenous source of ATP 
(100 µ M, n=6), as this has been shown to stimulate P2 
receptor-dependent RVD responses (Dezaki et al. 
2000, Schwiebert et al. 1995).  Although I predicted this 
would enhance RVD, the degree by which cells were 
able to regulate their volume was unaffected by 
increasing their exogenous ATP source.  Specifically, 
volume recovery of ATP-treated cells matched that of 
control cells (Figure 12A), as did the percent volume 
recovery at both 40 and 90 min (Figure 12B). 
One potential method by which Ca2+ could 
stimulate volume recovery would be to directly activate 
K+ efflux.  To assess this possibility, I used quinine (1 
mM, n=5), a Ca2+-activated K+ channel antagonist 
(Bergeron et al. 1996, Hoffman et al. 1986).  Quinine 
had no significant effect on the RVD response of 
alligator red blood cells (Figure 13A).  Specifically, there 
was no difference in the overall volume recovery of  
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Figure 4.  Cells failed to regulate their volume in the absence of extracellular Ca2+.  
 (A)  At time 0, cells were exposed to hypotonic shock, which resulted in a rapid rise in cell volume.  Following this initial swelling, control 
cells recovered toward their normal size over a 90 min time course.  In contrast, cells in a low Ca2+ medium remained swollen (n=5, 
P<0.001 at 90 min compared to control).  (B)  Percent volume decrease was significantly inhibited in the absence of extracellular Ca2+, both 
at 40 min (n=5, P<0.001 compared to control at 40 min) and at 90 min (n=5, P<0.001 compared to control at 90 min).  Cells swelled in both 
instances, as indicated by the negative percent volume recoveries of -5% (40 min) and -8% (90 min) compared to the control cells’ percent 
volume recoveries of 31% (40 min) and 50% (90 min).  Values represent mean + standard error. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.  Lanthanum treatment potentiated cell volume recovery. 
(A)  At time 0, cells were exposed to hypotonic shock.  Lanthanum-treated cells expressed a substantially enhanced cell volume recovery 
compared to control cells, both in terms of rate and final cell volume (n=5, P<0.001 at 90 min).  (B)  Control cells decreased in volume by 
30% and 49% at 40 min and 90 min, respectively.  However, cells treated with lanthanum had remarkably recovered by 87% and 92% at 40 
min and 90 min, respectively (n=5, P<0.001 for both 40 and 90 minutes).  Values represent mean + standard error. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.  Treating cells with gadolinium enhanced cell volume recovery after exposure to a hypotonic medium. 
  (A)  Gadolinium-treated cells had more successfully regulated their volume after 90 minutes when compared to control cells (n=5, P<0.05 
at 90 min).  (B)  The rate of volume recovery of gadolinium-treated cells was elevated to 73% at 40 min and 83% at 90 min compared to 
control values of 32% at 40 min and 47% at 90 min (n=5, P<0.001 at both 40 and 90 min).  Values represent mean + standard error. 
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Figure 7.  Removing extracellular Ca2+ inhibited volume recovery, and gramicidin reversed this inhibition.  
(A)  At time 0, cells were challenged with a hypotonic medium.  RVD was inhibited by the removal of Ca2+ from the extracellular medium 
(n=7, P<0.001 at 90 min compared to control).  However, with the addition of gramicidin (added at 30 sec, n=5), volume recovery exceeded 
that of control cells (P<0.01 at 90 min compared to control), even in the absence of extracellular Ca2+ (B)  Percent volume recovery was -
13% at 40 min and -16% at 90 min in EGTA-treated cells compared to control cell percent volume recovery of 18% at 40 and 90 min (n=5, 
P<0.01 at 40 and 90 min).  Percent volume recovery of gramicidin-treated cells (n=5) was enhanced to 36% compared to control cell 
percent volume recovery of 18% at 90 min (P<0.05 at 90 min).  Values are mean + standard error. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.  A23187 inhibited recovery following hypotonic shock in alligator cells.   
(A) Control cells gradually recovered from cell swelling, whereas A23187-treated cells continued to increase in volume over the 90 min time 
course studied (n=6, P<0.001 at 90 min compared to control).  (B)  Following hypotonic shock, control cells recovered their volume by 13% 
and 18% at 40 and 90 min, respectively.  In contrast, A23187-treated cells displayed a negative percent volume recovery of -42% at 40 min 
(n=6, P<0.001 compared to control) and -48% at 90 min (n=6, P<0.001 compared to control).  Values are mean + standard error.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.  Gadolinium inhibited regulatory volume decrease of alligator red blood cells. 
 (A)  Unlike control cells, which slowly recovered toward steady state cell volume following hypotonic shock, recovery was abolished in 
gadolinium-treated cells (n=7, P<0.01 at 90 min compared to control cells).  (B) Alligator red cells exposed to gadolinium showed a percent 
volume recovery of -3% and -9% at 40 and 90 min respectively.  This was in comparison to control cell percent volume recovery of 18% at 
the corresponding times (n=7, P<0.001 at 40 min and P<0.01 at 90 min). Values are means + standard error. 
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Figure 10.  Cell volume recovery was attenuated in the presence of hexokinase. 
 (A)  Hexokinase-treated cells remained more swollen throughout the 90 min time course than control cells (n=6, P<0.01 at 90 min 
compared to control).  (B)  Percent volume recovery of hexokinase-treated cells was limited to 2% at both 40 and 90 min.  This was in 
contrast to control cells, which showed a percent volume recovery of 13% and 15% at 40 and 90 min, respectively (n=6, P<0.01 at 40 min 
and P<0.001 at 90 min compared to control).  Values are mean + standard error. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11.  Suramin reduced alligator cell volume recovery. 
 (A) Addition of suramin to the extracellular medium limited the ability of cells to reduce in volume over the 90 min time course (n=5, P<0.05 
at 90 min compared to control).  (B)  In the presence of suramin, percent volume recovery was reduced to 6% at 40 min and 9% at 90 min, 
in comparison to control cell percent volume recovery of 16% and 19% at the corresponding times (n=6, P<0.01 at 40 min and 90 min).  
Values are mean + standard error. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12.  Addition of ATP to the extracellular medium had no effect on regulatory volume decrease.  
 (A)  Cells bathed in a hypotonic medium containing ATP showed a volume recovery response that paralleled the response of control cells 
(n=6).  (B)  Percent volume recovery of ATP-treated cells was equivalent to control cell percent volume recovery at both 40 and 90 min 
(n=6).  Values are mean + standard error. 
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Figure 13.  Quinine failed to inhibit volume recovery of alligator cells. 
(A)  After exposure to hypotonic shock, there was no significant difference in the overall volume recovery of quinine-treated cells when 
compared to control cells (n=5).  (B)  Quinine-treated cells and control cells displayed similar percent volume recoveries, both at 40 and 90 
min (n=5).  Values are means + standard error. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14.  Pimozide-treated cells and control cells responded similarly to hypotonic challenge. (A)  There was no significant 
difference between control cell volume recovery and cell volume recovery of pimozide-treated cells (n=5).  (B)  There was no difference 
between the percent volume recovery of control and pimozide-treated cells at either 40 min or 90 min (n=5). Values are means + standard 
error. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15.  ONO-RS-082 abolished the RVD response of alligator cells.  
(A)  Control cells gradually recovered toward resting cell volume following hypotonic shock, but cells treated with ONO showed no volume 
recovery response and instead continued to swell over the 90 min time course (n=5, P<0.001 at 90 min compared to control cells).  (B)  
Upon ONO treatment, a reduction in alligator cell percent volume recovery to -2% and -8% was observed at 40 and 90 min, respectively.  
This was in contrast to control cell percent volume recovery of 16% and 17% at the corresponding times (n=5, P<0.01 at 40 min and 
P<0.001 at 90 min).  Values are mean + standard error. 
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Figure 16.  DHAP attenuated percent volume recovery of alligator cells.  (A)  There was no significant difference in the final volume of 
control cells and DHAP-treated cells.  (B)  Addition of DHAP reduced percent volume recovery to 11% and 12% at 40 and 90 min, 
respectively.  This was in contrast to control cells, which recovered by 16% and 19% at the corresponding times (n=6, P<0.05 at 40 min 
and 90 min).  Values are mean + standard error. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17.  ETYA had no effect on cell volume recovery.  (A)  There was no difference in the volume of ETYA-treated cells and control 
cells at 90 min (n=6).  (B)  The percent volume recovery of ETYA-treated cell matched that of control cells (n=6).  Values are mean + 
standard error. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18.  NDGA-treated cells displayed a potentiated volume recovery response following hypotonic challenge. 
 (A)  Cells exposed to NDGA were slightly more successful in regulating their volume than control cells, as reflected in their smaller final 
volume (n=6, P<0.05 at 90 min compared to control cells).  (B)  The percent volume recovery of control cells and NDGA-treated cells was 
similar at 40 min (approximately 16%).  However, the percent volume recovery of 30% experienced by NDGA-treated cells at 90 min 
surpassed the 17% volume recovery of control cells at this time (n=6, P<0.01).  Values represent mean + standard error. 
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Agent Prediction Observed Effect on RVD 
 
 
EGTA 
 
 
Inhibition if Ca2+ is necessary for volume recovery 
 
Inhibition in salmon  
Inhibition in alligator  
 
A23187 
 
Enhancement if Ca2+ influx stimulates RVD 
 
Inhibition in alligator  
 
 
Gadolinium 
 
 
Inhibition if Ca2+ influx occurs through a SA channel 
 
Enhancement in salmon 
Inhibition in alligator  
 
Lanthanum 
 
Inhibition if Ca2+ entry occurs through a SA channel 
 
Enhancement in salmon  
 
Hexokinase 
 
Inhibition if Ca2+ entry occurs through a P2 receptor 
 
Inhibition in alligator  
 
Suramin 
 
Inhibition if Ca2+ entry occurs through a P2 receptor 
 
Inhibition in alligator 
 
ATP 
 
Enhancement if P2 receptor activity facilitates RVD 
 
No effect in alligator  
 
Gramicidin 
 
Enhancement of K+ efflux is required for volume recovery 
 
Reversed inhibition in alligator 
 
Quinine 
 
Inhibition if K+ efflux occurs via a Ca2+-activated K+ channel 
 
No effect in alligator 
 
Pimozide 
 
Inhibition if RVD requires calmodulin activation 
 
No effect in alligator 
 
ONO-RS-082 
 
Inhibition if volume recovery is PLA2-dependent 
 
Inhibition in alligator 
 
2,3 DBAP 
 
Inhibition if volume recovery is PLA2-dependent 
 
Inhibition in alligator 
 
ETYA 
 
Inhibition if an eicosanoid stimulates RVD 
 
No effect in alligator 
 
NDGA 
 
Inhibition if a leukotriene is needed for volume decrease 
 
Enhancement in alligator 
 
Table 2.  Pharmacological agents used in cell volume studies, my predictions as to their effects, and the experimental outcomes 
of their usage. 
 
quinine-treated cells in comparison to control cells 
(Figure 13A).  Likewise, the percent volume recovery of 
cells was unchanged by the addition of quinine (Figure 
13B). 
I then turned my attention to the various Ca2+-
mediated intracellular signaling cascades that might be 
initiated during RVD.  I used pimozide (10 µ M, n=5), a 
blocker of calmodulin activity (Bergeron et al. 1996, 
Hoffman et al. 1986, Huang et al. 2001), to address the 
possibility of the involvement in this Ca2+ binding protein 
in alligator RVD.  Pimozide had no significant effect on 
alligator cell volume regulation, as the RVD response of 
pimozide-treated cells paralleled that of control cells 
(Figure 14A).  There was no difference in percent 
volume recovery of pimozide-treated cells compared to 
unmanipulated control cells, either (Figure 14B). 
Having ruled out calmodulin, I next targeted 
arachidonic acid metabolism because this also is a 
Ca2+-activated system.  I blocked arachidonic acid 
production using ONO-RS-082 (10 µ M, n=5).  This 
agent is a potent inhibitor of phospholipase A2 (Light et 
al. 1998, Nakashima et al. 1989), a Ca2+-activated 
enzyme that functions to release arachidonic acid from 
the phospholipid bilayer (Balsinde et al. 1999).  Treating 
cells with ONO abolished their ability to regulate their 
volume (Figure 15A, P<0.001 at 90 min compared to 
control cells).  In fact, ONO-treated cells continued to 
swell over the time course studied (Figure 15B, P<0.01 
at 40 min and 90 min). 
The results of my ONO studies implicated 
PLA2 involvement in alligator RVD, as inhibiting this 
enzyme resulted in the failed ability of cells to reduce in 
volume following cell swelling.  To further confirm a role 
for PLA2, I used 2,4-dibromoacetophenone (5 µ M, 
n=6), a PLA2 inhibitor (Balsinde et al. 1999).  Although 
this agent’s effect on the relative volume of alligator 
cells at 90 min fell shy of statistical significance (Figure 
16A), it did significantly reduce the percent volume 
recovery at both 40 and 90 min (Figure 16B, P<0.05 
compared to control cells). 
Arachidonic acid could act directly on ion 
channels or could be metabolized further into 
eicosanoids, which in turn can activate K+ channels.  To 
determine whether it was arachidonic acid or an 
eicosanoid stimulating K+ efflux in alligator cells, I used 
5,8,11,14-eicosatetraynoic acid (10 µ M, n=6), an 
agent that blocks the production of all eicosanoids (Lehr 
& Griessbach 2000).  This antagonist had no effect on 
RVD.  That is, the final cell volume of ETYA-treated 
cells was not significantly different to that of control 
cells (Figure 17A).  Likewise, no difference in percent 
volume recovery was apparent at either 40 or 90 min 
(Figure 17B), suggesting eicosanoid formation is not 
necessary for volume recovery. 
Nonetheless, I still examined the role of the 
lipoxygenase pathway of arachidonic acid metabolism 
to ensure that the lack of effect following ETYA 
treatment was not due to this agent’s relatively low 
potency.  I treated cells with nordihydroguaiaretic acid 
(10 µ M, n=6), an effective inhibitor of the lipoxygenase 
pathway (Lambert et al. 1987).  This agent had a 
modest potentiating effect on alligator RVD.  
Specifically, cells treated with NDGA showed a more 
extensive volume recovery, indicated by their reduced 
final cell volume compared to control cells (Figure 18A, 
P<0.05 at 90 min compared to control).  Additionally, 
the rate of volume recovery was potentiated in NDGA- 
treated cells, which showed a final percent volume 
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recovery exceeding that of control cells (Figure 18B, 
P<0.01 at 90 min). 
The results of my cell volume studies are 
summarized in Table 2.  Listed are the various agents I 
used in my experiments, the predictions I made as to 
the outcomes of my studies, and my actual 
experimental findings. 
 
Discussion 
 
A role for Ca2+ in salmon RVD 
 
Cell volume recovery was dependent on 
extracellular Ca2+  
 
The findings of my study are consistent with a role for 
Ca2+ in regulatory volume decrease.  That is, in a low 
Ca2+ environment, salmon red blood cells failed to 
recover from the rapid swelling that accompanied 
hypotonic shock (Figure 4).  Furthermore, the Ca2+ 
source needed for the RVD response appears to be 
extracellular in origin, because if intracellular Ca2+ was 
the main source involved, then removal of extracellular 
Ca2+ should not have inhibited volume recovery.  And if 
both intracellular and extracellular Ca2+ played a role in 
RVD, then even in the absence of an extracellular Ca2+ 
source, cells might have experienced a partial volume 
recovery.  Therefore, my results indicate that 
extracellular Ca2+ plays the critical role in activating the 
RVD transduction pathway, thus supporting my original 
hypothesis. 
This finding is in agreement with the 
microscopy studies of Light et al. (2005). Specifically, if 
the conclusion that extracellular Ca2+ is needed for 
volume regulation is correct, then one would expect a 
rise in intracellular Ca2+ levels to follow hypotonic 
exposure in order to activate the RVD response.  Light 
et al. (2005) showed that an elevation in Ca2+ 
concentration does indeed occur (Figure 1).  
Additionally, they assessed the source of this Ca2+ by 
bathing salmon cells in a hypotonic, low Ca2+-EGTA 
Ringer.  In this environment, fluorescence was virtually 
abolished.  This reinforces my suggestion that 
hypotonic shock is followed by Ca2+ influx from the 
extracellular medium as opposed to Ca2+ release from 
intracellular storages. 
The  conclusion that Ca2+ influx plays the 
predominant role in elevating intracellular Ca2+ levels is 
shared by Rothstein & Mack (1992), who determined 
that the increasing cytosolic Ca2+ concentration 
accompanying hypotonic shock of Madin-Darby canine  
 
kidney cells is due to influx from the extracellular 
environment as opposed to release from intracellular 
stores.  They found that use of EGTA to form a low 
Ca2+ hypotonic medium inhibits this increase.  The 
results of McCarty & O’Neil (1990) further corroborate 
this finding; they failed to observe a rise in cytosolic 
Ca2+ upon removal of Ca2+ from the hypotonic medium 
in proximal tubules.  However, in other cell types, the 
rise in Ca2+ concentration appears to be the result of 
both influx from the extracellular medium as well as 
release from the intracellular medium.  This is the case, 
for example, in rat cultured suspended cerebellar 
astrocytes (Morales-Mulia et al. 1998).  Additionally, it 
should be noted that hypotonic shock does not 
invariably cause a rise in intracellular Ca2+.  For 
example, Kanli & Norderhus (1998), who tracked 
intracellular Ca2+ levels using epifluorescence, 
observed no change in the degree of fluorescence upon 
hypotonic stimulation of trout proximal renal tubules.  
Clearly, the specific events that occur as a result of 
changing extracellular osmolality vary as a function of 
cell type. 
Although my results suggest that extracellular 
Ca2+ is the primary activator of the RVD response, more 
complex mechanisms than the one I proposed above 
could be responsible for the volume recovery 
mechanism employed by salmon cells.  For example, 
extracellular Ca2+ might function to stimulate release of 
Ca2+ from intracellular storages, and the release of this 
Ca2+ source, in turn, might then be responsible for 
activation of downstream RVD processes (McCarty & 
O’Neil 1992).  If such a sequence of events was 
responsible for volume recovery, then removal of 
extracellular Ca2+ would indeed inhibit this process, as 
the extracellular Ca2+-dependent event occurs 
upstream from that of intracellular Ca2+ release.  Such a 
cascade has been demonstrated by Tinel et al. (2002) 
using rabbit TALH cells.  In this cell type, Ca2+ release 
from intracellular stores is dependent on Ca2+ influx 
from the extracellular medium.  When Ca2+ influx and, in 
turn, Ca2+ release, was blocked using a low Ca2+ 
Ringer, cells were unable to recover from hypotonic 
challenge.  Future studies could address this possibility 
in salmon red blood cells by exposing the cells to 
pharmacological agents that deplete intracellular Ca2+ 
stores, such as thapsigargin, ryanodine, or caffeine 
(Morales-Mulia et al. 1998, Quesada et al. 1999, Tinel 
et al. 2002).  If the primary role of extracellular Ca2+ is to 
stimulate Ca2+ release, then use of these agents prior to 
hypotonic exposure should inhibit RVD, even in the 
presence of extracellular Ca2+. 
Hypotonic shock RVD 
Ca2+ 
Cell at resting 
volume 
Swollen cell Recovered cell 
Figure 19. Proposed pathway for volume recovery of salmon red blood cells.  
 Hypotonic challenge leads to a rise in intracellular Ca2+ as a result of influx from the extracellular 
medium by way of a  gadolinium- and lanthanum-insensitive transport pathway.  The rise in Ca2+ 
activates the RVD response, allowing for volume recovery.  Additionally, Na+ influx at the onset of 
RVD might attenuate volume decrease. 
Na+ ?? 
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Extracellular Ca2+ influx did not occur through 
lanthanum- or gadolinium-sensitive transport 
pathways 
 
Both lanthanum and gadolinium had similar, and 
unexpected, effects on the RVD response of salmon 
erythrocytes.  Specifically, these agents dramatically 
enhanced the rate of cell volume recovery (Figures 5 & 
6), which was contrary to my original prediction and the 
findings of other researchers (Adorante & Cala 1995, 
Rothstein & Mack 1992, Light et al. 2003).  
Furthermore, there is no clear explanation as to why 
these agents would potentiate volume decrease.  One 
possibility, however, is that gadolinium and lanthanum 
had non-specific effects that caused the blockage of 
Na+ influx.  To explain, both the fluorescent studies 
(Light et al. 2005) and EGTA studies show 
unequivocally that RVD in salmon cells is Ca2+-
dependent.  Therefore, it is unlikely that lanthanum and 
gadolinium blocked Ca2+ entry pathways, for if they did, 
cells would not have been able to respond appropriately 
to hypotonic challenge.  However, if these agents 
instead prevented Na+ entry into the cells, the result 
could be an enhanced volume recovery.  For instance, 
Garcia-Romeu et al. (1991) showed that Na+ influx at 
the onset of RVD attenuates volume recovery in 
rainbow trout erythrocytes.  Although few studies 
identify a weakening effect of Na+ on the RVD response 
as proposed here, the fact that rainbow trout is a close 
relative to Atlantic salmon suggests that RVD in salmon 
might share similar characteristics to the RVD process 
observed by Garcia-Romeu at al. (1991).  Furthermore, 
there is evidence that lanthanides can be somewhat 
non-selective and block the influx of other cations 
besides Ca2+, including Na+ (Caldwell et al. 1998).  
Taking the limitations of these inhibitors’ specificities 
into account and my observation, the suggestion that 
they might block Na+ influx as opposed to Ca2+ influx in 
this cell type is not unreasonable. 
Furthermore, Na+ influx might play an 
important role in buffering the cell volume recovery 
response of salmon erythrocytes, because if lanthanum 
and gadolinium did inhibit Na+ influx, the result was a 
strikingly rapid RVD response compared to control 
cells.  In this sense, Na+ entry might serve to ensure 
that cells do not decrease in volume too quickly or too 
much; just as cell swelling can have devastating effects, 
a reduction in cell volume beyond a critical point is 
equally threatening to cell integrity.  Another possibility 
is that Na+ influx is a concomitant occurrence.  That is, 
it might serve no purpose in the overall RVD scheme, 
but at the same time, it might not be preventable.  For 
example, if cell swelling initiates the opening of non-
selective stretch activated cation channels, then these 
permeability pathways would inevitably allow for Na+ 
entry. 
Due to the unavailability of blood, I was 
unable to further study the salmon RVD response.  
Accordingly, future studies are needed to better 
pinpoint the events activated subsequent to cell 
swelling.  To assess more directly whether Na+ entry at 
the onset of RVD was indeed responsible for the 
observed effects of lanthanum and gadolinium, studies 
could be performed to examine the outcome of 
removing Na+ from the extracellular environment and 
replacing it with an impermeant cation such as N-
methyl-D-glucamine (NMDG).  If the proposed scenario 
outlined above is indeed what is occurring in this cell 
type, then inhibiting Na+ entry directly should also have 
an enhancing effect on RVD that mimics the effect 
observed in the gadolinium and lanthanum 
experiments. 
Finally, future studies are needed to 
determine what pathways are responsible for the Ca2+ 
influx essential for cell volume regulation by salmon red 
blood cells.   The findings of this study do not support 
Ca2+ entry through stretch-activated channels, as 
gadolinium and lanthanum failed to inhibit volume 
recovery.  Because gadolinium has also been shown to 
block P2 receptors (Nakazawa et al. 1997), this entry 
site does not seem likely, either.  This is consistent with 
the findings of Light et al. (2005), who examined the 
potential role for P2 receptors in salmon RVD.  They 
performed experiments using the ATP-scavenger, 
hexokinase, which inhibits P2 receptor activation.  They 
found this agent to have no significant effect on volume 
recovery, which indicates a P2 receptor-independent 
RVD response.  Considering that the specific Ca2+ entry 
site has yet to be determined for this cell type, future 
experiments using additional Ca2+ transport antagonists 
are required.  
 
Summary 
 
Taken collectively, my findings suggest that swelling of 
salmon erythrocytes triggers an influx of Ca2+ and the 
subsequent rise in intracellular Ca2+ levels.  This, in 
turn, plays a role in activating the volume regulatory 
response (Figure 19). 
 
RVD in alligator erythrocytes is Ca2+-dependent 
 
Extracellular Ca2+ was necessary for volume 
recovery of alligator red blood cells 
 
Similar to my results from salmon (Figure 4), alligator 
cells placed in a hypotonic medium lacking Ca2+ failed 
to recover toward steady state cell volume (Figure 7).  
This finding is consistent with Ca2+ playing a primary 
role in alligator volume recovery, which is not 
surprising; as mentioned previously, such a Ca2+-
dependent RVD response is common among numerous 
cell types (Christensen 1987, Hoffman et al. 1986, Light 
et al. 1998, Rothstein & Mack 1992).  This most likely 
reflects the ubiquitous nature of this signal molecule. 
Taking into account the Ca2+-dependent 
nature of alligator RVD, I hypothesized that increasing 
plasma membrane permeability to Ca2+, which allows 
for increased Ca2+ influx, should enhance the RVD 
process.  However, the results of my studies using the 
calcium ionophore A23187 contradicted this prediction.  
Unexpectedly, this agent dramatically inhibited volume 
recovery following hypotonic shock (Figure 8).  
Therefore, it appears that in this cell type, a subtle rise 
in intracellular Ca2+ might be required to activate RVD, 
whereas a dramatic rise might have the opposite effect.  
The lack of RVD rate enhancement upon large 
increases in intracellular Ca2+ is not restricted to 
alligator erythrocytes (McCarty and O’Neil 1992). For 
instance, Montrose-Rafizadeh & Guggino (1991) found 
that in rabbit medullary thick ascending limb cells, the 
rate of RVD is proportional to intracellular Ca2+ 
concentration only when this concentration is lower 
than basal Ca2+ levels.  They concluded that the resting 
Ca2+ concentration in this cell type is sufficient to fully 
maximize the RVD response, which explains why an 
increase in Ca2+ cannot further enhance the rate of 
volume recovery.  Beck et al. (1991) also found that no 
rise in intracellular Ca2+ is necessary for RVD in rabbit 
proximal convoluted tubules.  Although Ca2+ appears to 
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be involved in the RVD process in this cell type (as 
removing Ca2+ attenuates volume recovery), the 
observed increase in intracellular Ca2+ following 
addition of A23187 did not result in RVD rate 
enhancement.   
Similarly, it might be that alligator cells have a 
low Ca2+ threshold such that only a slight increase in 
Ca2+ is needed to fully saturate the Ca2+-stimulated 
volume recovery response.  However, many cell types, 
including Necturus erythrocytes (Light et al. 2003), 
dissociated epithelial cells (Rothstein & Mack 1990), 
and proximal tubules (McCarty & O’Neil 1990) do not 
display such a low Ca2+ threshold.  In these cell types, 
fairly large increases in cytosolic Ca2+ (achieved by 
A23187 addition) do, indeed, potentiate volume 
recovery.  The dissimilarity in Ca2+ sensitivity among 
cell types might be due to differences in the cellular 
machinery involved in their RVD processes or 
differences in the specific role played by Ca2+ in their 
volume recovery mechanisms. 
The fact that alligator cells responded in an 
inhibitory fashion to A23187, as opposed to showing no 
response, was rather puzzling.   This observation is 
best explained as a concentration effect—small 
increases in Ca2+ levels stimulate RVD, whereas 
pharmacological increases inhibit the volume recovery 
process.  Additionally, A23187 might have a permissive 
effect on both Ca2+ and Na+ entry into cells (Escobales 
& Canessa 1985).  And sodium influx, in turn, could 
result in additional cell swelling (Garcia-Romeu at al. 
1991).  Because some researchers suggest that cell 
swelling itself plays a role in inactivating certain aspects 
of the RVD process (McCarty & O’Neil 1990), excessive 
Na+ entry might prematurely arrest the volume recovery 
process in alligator cells, accounting for the dramatic 
inhibition of RVD following A23187 treatment.  
However, experimental evidence must be obtained to 
draw more definitive conclusions.  Specifically, studies 
in which the concentration of A23187 used or the 
concentration of Ca2+ present in the extracellular 
medium is adjusted would be useful.  By observing the 
effects of such manipulations on volume recovery, 
insight into the effects of A23187 on alligator RVD 
might be gained. 
 
Extracellular Ca2+ functioned to activate K+ efflux 
 
It appears that Ca2+ is involved in stimulating K+ efflux 
from alligator cells.  Support for this conclusion comes 
from the finding that the cationophore gramicidin 
reversed the inhibitory effect of extracellular Ca2+ 
removal (Figure 7), which was the expected result if 
Ca2+ has a permissive effect on K+ efflux.  The finding 
that K+ efflux is a crucial component of alligator RVD is 
consistent with virtually all cell types studied to date 
(Chamberlin & Strange 1989, McCarty & O’Neil 1992, 
Pasantes-Morales et al. 2000).  Furthermore, other 
researchers have similarly concluded that this efflux is 
Ca2+ dependent.  For example, Adorante & Cala (1995) 
found that Ca2+ stimulates K+ efflux in nonpigmented 
human ciliary epithelial cells, as the inhibition of RVD by 
Ca2+ chelation was removed with the addition of 
gramicidin.  Likewise, Light et al. (2003) found that 
gramicidin reverses the RVD inhibition that 
accompanies EGTA treatment of Necturus 
erythrocytes.  These parallel findings lend support for 
the results of this study. 
 
 
Ca2+ influx occurred through gadolinium-sensitive 
ion channels 
 
Consistent with my original hypothesis, a gadolinium-
sensitive channel appears to account for the Ca2+ influx 
needed to activate the RVD response in alligator cells, 
because gadolinium-treated cells showed a complete 
inability to regulate their volume (figure 9).  The 
response of alligator cells to this antagonist is not 
unique, for similar results have been obtained from 
studies on rat lacrimal acinar cells (Speake et al. 1998) 
as well as on Necturus erythrocytes (Light et al. 2003).  
These similarities suggest that some continuity exists in 
terms of calcium entry pathways.  However, 
interestingly, the membrane transport pathway active in 
alligator RVD appears to be fundamentally different to 
that stimulated in response to salmon cell swelling 
(figure 6).  That is, salmon cells displayed the complete 
opposite response to gadolinium treatment. 
 In addition, it seems that the gadolinium-
sensitive transport pathway involved in Ca2+ entry into 
alligator cells is, at least in part, a P2 receptor in 
contrast to a stretch-activated channel.  Evidence for 
this can be seen in figures 10 and 11, which reveal that 
inhibition of alligator RVD occurred following addition of 
the ATP-scavenger hexokinase and the P2 receptor 
antagonist suramin.  Thus, a role for P2 receptors in the 
volume recovery response of alligator cells is supported 
by this study.  Similarly, in Necturus red blood cells, 
RVD is dependent on P2 receptor activation, which is 
followed by the increase in cytosolic Ca2+ required to 
stimulate RVD (Light et al. 1999).  Dezaki et al. (2000) 
also showed that in a human epithelial cell line, 
hypotonic shock triggers the release of ATP into the 
extracellular medium, the subsequent activation of P2 
receptors, and an increase in intracellular Ca2+.  The 
fact that the findings of Light et al. (1999) and Dezaki et 
al. (2000) are consistent with this study strengthens the 
notion of a P2 receptor-mediated RVD mechanism. 
However, unlike Necturus erythrocytes (Light 
et al.1999) and human epithelial cells (Dezaki et al. 
2000), it appears that alligator cells release sufficient 
ATP at the onset of the RVD response to fully saturate 
their P2 receptors.  Whereas ATP addition to the 
extracellular medium enhanced volume recovery in 
Necturus and human epithelial cells, no effect was 
observed upon ATP addition to alligator cells (Figure 
12).  Therefore, the most logical conclusion, based on 
the fact that P2 receptors do appear to be necessary in 
alligator RVD, is that they are maximally active under 
normal conditions.  In future studies, ATPγ S, a non-
hydrolyzable form of ATP (Light et al. 2001) could be 
used.  This might discern whether the lack of effect 
upon ATP addition observed in this study was indeed 
the result of receptor saturation, or, alternatively, if 
these cells have very active exo-ATPases (Gordon 
1986) that prevent the rise in extracellular ATP 
concentration necessary to observe an enhanced 
volume recovery. 
It should be noted that the inhibition of RVD 
evoked by hexokinase and suramin was not as robust 
as that of gadolinium.  This suggests that P2 receptors 
might not be entirely responsible for Ca2+ entry during 
RVD.  In addition to a P2 receptor, another gadolinium-
sensitive transport pathway (such as a stretch-activated 
channel) could also be active during the volume 
recovery process.  In future studies, using additional P2 
receptor antagonists, in particular those specific for P2X 
receptors, would be beneficial for further elucidation of 
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the specific Ca2+ transport pathways functioning in this 
cell type. 
 
K+ efflux does not occur through Ca2+-activated K+ 
channels 
 
The effect of gramicidin on RVD in alligator erythrocytes 
suggested that the rate limiting step in volume recovery 
was K+ efflux, as facilitating K+ loss from cells with 
exogenous pores resulted in a more efficient RVD 
response (Figure 7).  Furthermore, it appears that Ca2+ 
had a permissive effect on K+ efflux, as I was able to 
reverse the inhibitory effect of a low-Ca2+ medium by 
artificially permitting K+ loss from alligator cells.  As 
mentioned earlier, this was the expected result if K+ 
efflux occurs downstream of Ca2+ entry into cells.  
However, my results suggest that Ca2+ does not 
modulate K+ permeability directly, because quinine, a 
Ca2+-gated K+ channel blocker (Hoffman et al. 1986), 
had no significant effect on volume recovery (Figure 
13).  That is, it is unlikely that Ca2+ stimulates K+ efflux 
by binding to and activating a K+ efflux site, as such a 
channel does not appear to be operating in alligator 
erythrocytes during the RVD response.   Similar results 
were found by Arrazola et al. (1993) in rat thymocytes.  
In this cell type, RVD was unaffected by the addition of 
quinine.  Similarly, K+ efflux during cultured lens 
epithelial cell RVD occurs via a quinine-insensitive 
transport pathway (Diecke & Beyer-Mears 1997).  
However, in the case of alligator erythrocyte RVD, it is 
not possible to rule out the involvement of a Ca2+-
activated K+ channel entirely, as a quinine insensitive 
Ca2+-dependent K+ channel might be present and 
operating during volume recovery.  In order to account 
for this possibility, experiments using other Ca2+-
activated K+ channel antagonists would have to be 
performed.  
The lack of an effect following quinine 
addition to alligator red blood cells is in contrast to the 
studies performed by Hoffman et al. (1986) on Erlich 
ascites tumor cells, Adorante & Cala (1995) on 
nonpigmented human ciliary epithelial cells, and 
Bergeron et al. (1996) on Necturus red cells.  In these 
cell types, quinine did have an inhibitory effect on RVD, 
which lends support to Ca2+ activated K+ channels 
being present in these cell types.  Therefore, although 
K+ efflux is a universal step in the volume recovery 
process, the pathway for this efflux seems to vary 
among cell types. 
 
RVD does not involve a Ca2+/calmodulin signaling 
pathway 
 
Since Ca2+ did not appear to directly activate K+ efflux 
during alligator RVD, I assessed whether a signal 
transduction pathway involving calmodulin is at play in 
alligator erythrocytes. Although calmodulin has been 
implicated in the RVD process in many cell types 
(McCarty & O’Neil 1992), it does not seem to play a role 
in alligator volume recovery.  That is, I failed to observe 
an inhibitory effect in response to preventing calmodulin 
activation with pimozide (Figure 14).  Hence, it seems 
unlikely that RVD in alligator cells is modulated by a 
calmodulin system.  
Calmodulin-independent transduction 
pathways similar to the one found in alligator cells have 
been identified in other cell types.  For example, 
Fincham et al. (1987) showed that the response of 
erythrocytes from euryhaline fish species to hypotonic 
shock is independent of calmodulin activation.  
Additionally, Schliess et al. (1996) determined that 
calmodulin is not involved in the cell signaling events 
stimulated by cell swelling in rat cerebral astrocytes.  
The fact that both calmodulin dependent and 
independent signaling processes have been observed 
implies that there are variations in the steps ultimately 
leading to volume restoration. 
 
RVD depends on Phospholipase A2 activation and 
arachidonic acid production 
 
The results of my PLA2 inhibition studies were in 
agreement with my early predictions.  Specifically, as 
was expected if PLA2 activation is a crucial component 
to the RVD response, the PLA2 antagonist ONO had a 
robust inhibitory effect on the ability of alligator cells to 
regulate their volume (Figure 15). Additionally, the PLA2 
inhibitor 2,4-dibromoacetophenone attenuated percent 
volume recovery in alligator cells (Figure 16).  In 
combination, these findings imply that arachidonic acid 
and/or its metabolites are efficacious in alligator volume 
recovery.   As stated previously, a role for arachidonic 
acid in volume recovery following hypotonic challenge 
is not unique to this cell type; RVD in neuroblastoma 
(Pasantes-Morales et al. 2000), Necturus erythrocytes 
(Light et al. 1998), and trout proximal renal tubules 
(Kanli & Norderhus 1998) all involve arachidonic acid 
metabolism. 
It appears that in alligator erythrocytes, 
arachidonic acid itself, as opposed to one of its 
metabolites, potentiates the RVD signaling cascade.  
Support for this conclusion comes from the observation 
that suppressing the formation of all eicosanoids (the 
further breakdown products of arachidonic acid) using 
ETYA failed to inhibit volume regulation (Figure 17).  
Interestingly, the more specific antagonist NDGA (an 
inhibitor of the lipoxygenase pathway thereby blocking 
production of leukotrienes) slightly potentiated volume 
recovery (Figure 18).  If anything, this result further 
supports the direct role I propose for arachidonic acid in 
alligator cell volume regulation.  That is, by blocking 
arachidonic acid breakdown, NDGA might enhance 
RVD by increasing the concentration of arachidonic 
acid available to participate in volume restoration.   
A primary role for arachidonic acid itself in 
volume regulation is consistent with the findings of 
other researchers.  Basavappa et al. (1998) found that 
inhibiting arachidonic acid formation in human 
neuroblastoma cells results in a reduced RVD.  
However, similar to this study, RVD inhibition was not 
observed upon selective blockade of arachidonic acid 
breakdown.  Sanchez-Olea et al. (1995) also showed 
that arachidonic acid stimulates RVD in astrocytes 
directly; RVD was significantly affected in the absence 
of the fatty acid itself, whereas antagonizing its further 
metabolism did not alter RVD.  In contrast, if an 
arachidonic acid metabolite was required to stimulate 
RVD, then blocking its formation would attenuate 
volume recovery.  This has been shown to occur in 
kidney cells (Tinel et al. 2000), where addition of ETYA 
results in a weakened RVD mechanism.  Additional 
support for arachidonic acid metabolites as volume 
recovery agents comes from studies performed on 
Necturus erythrocytes (Light et al. 1997).  In this cell 
type, both ETYA and NDGA had inhibitory effects on 
RVD, indicating a volume regulatory response 
dependent on a lipoxygenase metabolite. 
Obviously, there is a clear continuity with 
respect to the RVD mechanisms among cell types, as 
many of them involve a signal transduction pathway 
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dependent on arachidonic acid.  At the same time, 
however, obvious differences are apparent, particularly 
when it comes to the degree of arachidonic acid 
metabolism required to stimulate the RVD response.  
This may reflect differences in the specific role played 
by arachidonic acid in the overall RVD scheme, which 
has yet to be elucidated in many cell types. 
Future studies should be performed to 
confirm a role for arachidonic acid in alligator volume 
regulation.  This might include utilizing additional PLA2 
inhibitors.  Also, using PLA2 inhibitors in coordination 
with the cationophore gramicidin would discern what 
role arachidonic acid plays in the RVD cascade.  If 
arachidonic acid mediates K+ efflux, then gramicidin 
should reverse the inhibitory effect of PLA2 inactivation.  
Additionally, experiments could be carried out in which  
 
Figure 20.  Proposed RVD signal transduction pathway in 
alligator red blood cells.   
Cell swelling leads to Ca2+ influx, possibly by activating a P2 
receptor.  The rise in intracellular Ca2+ stimulates PLA2, which 
catalyzes the breakdown of membrane phospholipids to form 
arachidonic acid.  Finally, the actions of arachidonic acid result 
in K+ efflux, thereby allowing for cell volume recovery. 
 
arachidonic acid is added to the extracellular medium.  I 
would expect this to enhance volume recovery, if RVD 
is indeed stimulated by arachidonic acid. 
 
Summary 
 
The results from my studies on alligator RVD are 
consistent with cell swelling being followed by the influx 
of Ca2+ through a gadolinium-sensitive entry site, 
possibly a P2 receptor.  In turn, calcium stimulates the 
volume regulatory response through the activation of 
PLA2 and the subsequent formation of arachidonic acid.  
Arachidonic acid leads to volume restoration by 
activating K+ efflux (Figure 20). 
 
Conclusion 
 
Ca2+ as a signaling agent in regulatory volume 
decrease 
 
Cell swelling appears to correlate with a rise in 
intracellular Ca2+ in both salmon and alligator red blood 
cells following an influx from the extracellular medium, 
as opposed to release from intracellular stores.  The 
increase in Ca2+ levels is not an epiphenomenon, as 
Ca2+ is needed to activate the RVD response.  
Therefore, it seems that Ca2+ is a pivotal signaling 
agent in the intracellular processes that allow for 
volume decrease following hypotonic challenge. 
 
Similarities and differences between the volume 
regulatory responses of salmon and alligator  
 
I observed both similarities and differences in the RVD 
mechanisms of the two cell types I used as models in 
my studies.  The most apparent similarity was the 
dependence on extracellular Ca2+ for volume recovery 
following cell swelling; neither cell type was able to 
respond appropriately to hypotonic challenge in the 
absence of this Ca2+ source.  This might reflect 
similarities in their RVD pathways, if Ca2+ is operating in 
a similar fashion in salmon and alligator cells.  
However, Ca2+ serves as an activator of a wide variety 
of cellular processes.  Thus, although RVD in both cell 
types clearly relies on Ca2+, it might be serving a 
different function in each species.  In alligator cells, 
Ca2+ appears to stimulate arachidonic acid formation, 
which then leads to K+ efflux.  I was unable to study the 
signaling cascade downstream of Ca2+ influx in salmon 
cells, but future research could examine this topic.  It 
would be interesting to determine whether RVD in 
salmon similarly occurs through a pathway mediated by 
arachidonic acid.   
The most obvious difference between salmon 
and alligator RVD is the rate and extent by which the 
cell types are able to recover from cell swelling.  
Salmon cells displayed a robust RVD response, 
whereas volume decrease by alligator cells was much 
less pronounced.  This difference might indicate that 
salmon erythrocytes possess a more highly tuned and 
efficient RVD mechanism.  This might be 
physiologically relevant, as severe hypotonic shock is 
probably a much greater threat to the cells of marine 
teleosts, especially those cells that travel through the 
gills.  In contrast, alligator cells are not directly exposed 
to the external environment.  Instead, it is likely that 
their RVD mechanism is adapted to counteract milder 
and more gradual osmotic fluctuations, such as those 
that accompany altered metabolic activity and kidney 
function during hibernation.  In other words, the differing 
lifestyles of these two organisms should be taken into 
account when comparing their RVD responses. 
 
Note: Eukaryon is published by students at Lake Forest 
College, who are solely responsible for its content.  The 
views expressed in Eukaryon do not necessarily reflect 
those of the College. Articles published within Eukaryon 
should not be cited in bibliographies. Material contained 
herein should be treated as personal communication 
and should be cited as such only with the consent of 
the author.    
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